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Evidence for the viral nature of the lactic dehydrogenase (LDH) agent, dis- 
covered in the plasma of many tumor-bearing mice by Riley (1), has been ob- 
tained by several laboratories (2, 3). The ability of this agent to cause an in- 
creased activity of a number of enzymes in mouse plasma (4), persisting during 
the lifetime of the host  (1)  without causing apparent cellular damage merits 
further study. 
This paper will present data on maintenance, titration, and partial purifica- 
tion of the LDH agent, its resistance toward organic solvents, its morphology 
and size as determined by electron microscopy, its activity as an interferon pro- 
ducer, and its lack of antigenicity. 
Materials and Methods 
Strain of LDH Agent.--The  strain was obtained from a naturally infected Ehrlich ascites 
carcinoma. This Ehrlich ascites strain had been maintained for 2 years in CDF1 mice (NIH 
strain). 
Infectivity Titer.--Infectivity  of the agent was assayed by injecting  0.1 ml of 10-fold serial 
dilutions, made in Eagle's medium plus 20 per cent veal infusion broth (5), into NIH G-P 
Swiss (20 to 25 gin) mice, 5 mice per dilution. Four to 5 days after inoculation blood was 
collected by orbital bleeding (6) with capillary pipettes, wetted with a heparin solution con- 
taining 1000 U.S.P. units heparin per ml, and pooled. LDH ~ctivity was determined on the 
plasma obtained from each pool by a modification of the method of Wroblewski and Ln Due 
(7). The number of infected mice at each dilution  was estimated from a scale representing the 
stepwise increase of LDH activity contributed by each additional infected mouse (m~/e  infra) 
and the results calculated by the Karber method. The titer was expressed as the negative 
logx0 dilution of the sample which induced an increased lactic  dehydrogenase activity in 50 
per cent of the mice (IDa0 per ml). 
Preparation of LDH Agent.--Blood plasma or ascitic fluid from Ehrlich ascitic carcinoma- 
bearing mice (v/de infra), infected 24 hours previously with the LDH agent, was harvested 
and centrifuged at 900 Rcz for 10 minutes. The supernatant was diluted with an equal volume 
of 0.3 M  potassium citrate and 0.003 per cent hyaluronidase, and digested at room tempera- 
ture for 1 hour (8). It was centrifuged at 4000 Rc]v for 20 minutes. The supernatant was de- 
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canted and recentrifuged at  10,000 ItcF for 6 minutes.  The resulting supematant  was again 
decanted and centrifuged at 105,000 Rcr for 2 hours in a Spinco model L ultracentrifuge. All 
centrifugations were done at 0 to 4 ° C. The pellet was resuspended in distilled water, in one- 
tenth of the original volume. Material prepared in this manner was used for the experiments 
presented below, unless otherwise indicated. If necessary, the agent, resuspended in distilled 
water, was stored at --25°C. 
Electron Microscopiv Examination.--Ultracentrifuged  pellets  of partially  purified  LDH 
agent were fixed in 1 per cent osmium tetroxide (buffered to pH 7.0),  dehydrated,  and em- 
bedded in maraglas (9). Sections were stained with lead citrate (10), and examined in an RCA 
EMU 3 E electron microscope. 
TABLE I  a 
Determination of the Infectivity  Titer  by Pooling the Plasma  of 5 Mice* 
LDH units per ml plasma 
No. mice infected 
Expected  SD  Class 
0/s 
1/5 
2/5 
3/5 
4/5 
5/5 
740 
1618 
2495 
3373 
4250 
5128 
108 
157 
194 
225 
252 
277 
0--1000 
1100-2000 
2100-2900 
3000-3700 
3800-4600 
4700- 
* The scale representing the stepwise increase in LDH-activity contributed by each addi- 
tional infected mouse is based on the LDH-activity of 67 control mice and 68 infected mice 
(see text). 
RESULTS 
Determination of the Infectivity Titer by Pooling the Plasma of 5 Mice.--A shortened 
procedure for the determination of the titer of the agent was desirable, since the con- 
ventional method, consisting of LDH assays on each of a  set of 5 individual mice (5), 
was  time-consuming.  Therefore,  a  rapid  method was  devised in which LDH  assays 
were performed on pooled plasma  of 5 mice. It will be seen, that  this method can be 
used when utmost precision is not required. 
The scale representing the stepwise increase in LDH activity contributed by each 
additional infected mouse was determined as follows: Sixty-seven individual control 
mice were bled  and  the LDH  activity  in  each plasma  was  determined.  The  mean 
concentration  was  740  4-  291 LDIt  units/ml,  the values ranging  from 400  to  1400 
units/ml. 
Similarly, the mean concentration of 68 infected mice was 5128  4- 751 LDH units/ 
ml, the values ranging from 3700 to 7000 units/ml. 
From these data a  table was constructed showing the expected LDH  content 
of pools of plasma from groups of 5 mice with various numbers infected, and the 
corresponding standard  deviations (Table  I  a). These values were used to form 
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a system of classes which minimized the chance of a classification error and from 
which the most probable  number of mice infected in each pool could be esti- 
mated. The IDs0/ml of the virus preparation was then calculated by the method 
of Karber (11). In Table I b are shown comparisons between the actual numbers 
estimated from the pooled plasma of the same mice, and the corresponding esti- 
TABLE  I  b 
Comparisons Between Actual Number of Mice Infected, and the Number Estimated 
from the Pooled Plasma of the Same Mice 
LDH Units/ml Plasma 
ID6o/ml (Log IO) 
/  I 
Log dilution  ......................  --8  --9  --10  --ll  --12 
Experiment i 
Mouse 1 
2 
3 
4 
5 
No. infected ............... 
Pooled plasma ............. 
Estimated No.  infected ..... 
5000 
4500 
5400 
6O0O 
5200 
5 
460O 
4 
4800 
4O00 
4OOO 
5200 
4700 
5 
4500 
4 
4OO 
4OO 
1300 
490O 
1 
1600 
1 
6OO 
500 
500 
900 
500 
0 
600 
0 
9001 
500 
600 
600 
800 
0 
600 
0 
9.75  4-  0.25" 
9.35  -4-  0.38 
Experiment g 
Mouse 1 
2 
3 
4 
5 
No. infected ............... 
Pooled plasma ............. 
Estimated No. infected  ...... 
6OOO 
4300 
46O0 
46O0 
5700 
5 
4500 
4 
5200 
1000 
44O0 
5500 
4800 
4 
3500 
3 
1000 
1000 
4800 
5400 
4OOO 
3 
2800 
2 
900 
5400 
500 
6OOO 
5800 
3 
3700 
3 
6OO 
500 
700 
700 
900 
0 
500 
0 
10.5  +  0.40 
9.9  ±  0.47 
Experiment 3 
Mouse 1 
2 
3 
4 
5 
No. infected ............... 
Pooled plasma ............. 
Estimated  No.  infected ..... 
5100 
4300 
46O0 
4900 
4200 
5 
44O0 
4 
5100 
5000 
5600 
6O00 
5300 
5 
5200 
5 
600 
6300 
900 
1200 
8000 
2 
2900 
2 
600 
1000 
800 
60O 
6OO 
0 
600 
0 
9OO 
700 
700 
1000 
6OO 
0 
6OO 
0 
9.9  -4-  0.25 
9.7  -4-  0.32 
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TABLE  I  c 
Comparison between actual number of mice infected, and the number, estimated from the pooled 
plasma of different mice, inoculated with the same virus dilaaons (experiments  1 and 2), and a 
comparison of the number infected, estimated from the pooled plasma of two sets of mice inocu- 
lated with duplicates of the same virus dilutions  (experiments 3 and 4). 
LDH Units/ml Plasma 
ID~o/ml 
(Log 10) 
Log  dilution  .......................  --6  --7  --8  --9  --10  --11  --12 
Experiment 1 
Mouse 1 
2 
3 
4 
5 
No. infected .............. 
Pooled plasma ............ 
Estimated  No.  infected .... 
46001626~  4500 
48001  1300 
S 
54001  4500 
50001  5900  5300 
46001  5100 
4 
62001  57001  4600  [ 
41 
5000 
6OOO 
5000 
5000 
5000 
5 
5100 
5 
1000 
1000 
70O0 
1100 
5100 
I 
2 
1900 
1 
--  9.7  4-  0.32* 
--  9.5  4-  0.28 
Experiment 2 
Mouse 1 
2 
3 
4 
5 
No. infected .............. 
Pooled plasma ............. 
Estimated No. infected  ...... 
B 
m 
B 
--  4500 
--  4700 
--  3700! 
--  4300  ; 
--  5500 
--  5 
--  5000 
--  5 
4500 
5300 
4200 
4500 
4600 
5 
6500 
5 
5001  900 
45001  600 
440011200 
9001  900 
55001  600 
0 
40001  1100 
1 
700 
700 ¸ 
8001 
6001 
5001 
10.1  -4-  0.25 
6001 
10.5  4-  0.28 
i 
Experiment 3 
~oo,ea~,~oa .............  -  -  ~  4~  ~  ~  9.~  ±  0.~0 
Estimated No. infected  ......  I 
~ooX~a~m~ .............  0~  ~  ~ 
Estimated No. infected  ......  600~  0~  9.9  ±  0.25 
Experiment  4 
Estimated No. infected  ......  I  ~  0  ±  0.20 
~oo~ea~m.  .............  ~  ~  ~  ~  90~,0.  ~ 
Estimated No. infected  ......  4-  0.25 
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mates of the IDs0. In Table I c are shown similar comparisons made on parallel 
series of mice. In experiments 1 and 2 the two sets of mice were infected with 
the same virus dilutions,  and the number of mice infected determined individ- 
ually, or from pooled plasma. In experiments 3 and 4 two sets of mice were in- 
fected with duplicate dilutions of the same virus preparation and the number 
of mice infected determined from pooled plasma. It is seen that there is agree- 
ment to within about a half logarithm in the estimated IDds, which is within 
the range of variability indicated by the standard deviations. 
Growing the Agent  in Quantity.--It  was found possible to obtain relatively 
large quantities  of the LDH agent by cultivating it in Ehrlich  ascites tumor 
bearing mice. 
CDF1 mice were inoculated intraperitoneally with 0.05 ml of an LDH agent-free 
Ehrlich  ascites ceU suspension.  Mter  7 days 0.1  ml of an  LDH agent  suspension 
(IDs0  =  108"°/ml) was  inoculated  into  the  swollen  peritoneal  cavity. The  ascitic 
fluid  (5  to  12  ml/mouse) was collected  24 hours after inoculation  with the agent, 
centrifuged,  and the LDH agent titer of the resulting supernatant was found to be 
equal to that of the plasma (i.e., 109.5 to 101°'~/ml). Occasionally the stock Ehrlich 
ascites carcinoma became contaminated with the LDH agent, resulting in low titers 
as are found in permanently infected animals.  Such strains could be freed of the agent 
by passing them once or twice through 7-day-old  suckling  rats, which  maintain the 
Ehrlich carcinoma but not the LDH agent (An Ehrlich ascites line is routinely main- 
tained in suckling rats and used when the mouse strain is found contaminated). This 
method of decontamination was previously reported by Rowson (12). 
Partial  Purification  of the LDH A gent.--Early attempts to purify the LDH 
agent were unsuccessful.  This was found to be due to the inactivation of the 
agent by the  saline used for resuspension of  sedimented  material.  However, 
at low  temperature  the  LDH  agent  is stable in either complex solutions  or 
distilled water (5).  Subsequently,  crude  preparations  were  stored  in  Eagle's 
medium with 20 per cent veal broth, and the preparations obtained after hyaluro- 
nidase digestion (see Materials and Methods) in distilled water. The latter prep- 
arations have been used for the studies presented here. 
As a first step to further purification, the effect of lipid solvents was studied. 
The inactivating effect of several organic solvents is presented in Table II. It 
can be seen that only after petroleum ether (PE) (petroleum benzin, Merck and 
Co.,  Inc.,  Rahway,  New  Jersey)  extraction  was  the  infectivity maintained. 
With  petroleum ether  (ligroine)  a  loss of one to two logs  in  infectivity  was 
found.  In all other solvents, a  loss of 5  to 7 logs in infectivity occurred.  Gas 
chromatography of the PE extracts from the LDH agent pellets indicated the 
presence of a  number of free and  esterified unidentified  fatty acids  of short 
chain length  (Cze or less). The remaining pellet residue was devoid of fats ex- 
tractable in a mixture of one volume methanol and 2 volumes chloroform. Ap- 592  LACTIC DEHYDROGENASE  AGENT 
parently  the  PE-extractable  lipids  are  not  essential  for  maintenance  of 
infectivity.  The  degree  of purification  obtained  by  the  hyaluronidase  treat- 
ment, followed by PE extraction is indicated by the results, presented in Table 
III, in which  the fiters  and the nitrogen  contents  of crude LDH agent,  hy- 
aluronidase-treated  LDH  agent,  and  PE-extracted  LDH  agent  are  given. 
Further purification of the PE-treated fractions is in progress. 
Effect of RNase on crude and PE-extracted LDH A gent.--Since it has been re- 
ported that an ether extract or cold phenol extract of the agent was infective 
TABLE  II 
Effect of Organic Solvents on LDH Agent* 
Original titer ID6o/ml  Titer after treatment§  Loss in infectivity 
Solvent~  (Log 10)  ID~/ml (Log. 10)  (Log 10) 
Pn  ................. 
PE. 
PE  ................ 
PE  ................ 
PE  ................ 
PE  ................ 
PE  ................ 
EE  ............... 
EE  ............... 
Alc  ................ 
Alc ................ 
CHCIsII  ........... 
CI-IC13 ............ 
9.5 
9.9 
9.5 
10.5 
10.5 
10.5 
10.3 
9.5 
8.9 
8.9 
9.5 
9.5 
8.9 
8.7 
9.5 
9.3 
10.5 
10.1 
10.7 
10.5 
<3.0 
3.9 
2.5 
3.5 
<3.0 
2.1 
0.8 
0.4 
0.2 
0.0 
0.4 
+O.2 
+O.2 
6.5 
5.0 
6.4 
6.0 
6.5 
6.8 
*  Hyaluronidase-treated preparations,  resuspended in  distilled water. 
PE, Petroleum ether (Petroleum benzin, Merck); EE, Ethyl ether; Alc., Ethyl alcohol. 
§ All samples were shaken manually with 5 volumes of solvents for 5 minutes at room tem- 
perature. 
[[ CHC13, -[-4 per cent isoamyl alcohol. 
and that this infectivity was destroyed by RNase, and not by DNase (3, 13), 
similar experiments were performed on the PE-purified LDH agent preparation. 
The results (Table IV) show that RNase did not inactivate intact crude LDH 
agent, nor PE-extracted LDH agent, indicating that the PE had not removed a 
protective coat, although lipids were removed. 
Morphology of the LDH A gent.--A number of hyaluronidase- and PE-purified 
pellets were prepared for electron microscopy. Figs.  1 a  and  1 b show typical 
particles found in pellets of purified LDH agent. These particles have never been 
observed in uninfected  control  preparations.  The  particles  consist  of  a  very 
dense inner ring of about 25 mt~ diameter and a less dense and sometimes indis- 
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free,  they are frequently seen within varying sized single-membraned vesicles, 
the smallest of which (Figs. 1 b and 1 c) could easily be construed as represent- 
ing a "tail" in a negatively stained preparation (14). Infrequently large double- 
membraned bodies have been observed to be filled with characteristic particles 
(Figs.  2  a  and  2  b).  The origin and possible significance of these membraned 
structures is under further investigation. 
TABLE III 
Partial Purification of LDH A gent* 
Exp~r~.  ent 
Crude prepara~ons 
IDi0/ml 
(Log. 10) 
9.7 
9.9 
9.9 
9.5 
mg N/ml 
3.0 
2.8 
3.0 
3.7 
10-fold Concentrated 
Hyaluronidase preparation 
ID6o/rnl 
(Log. 10)  mg N/ml 
10.5  0.15 
10.5  0.14 
10.5  0.48 
10.3  0.38 
PE extracted preparation 
IDso/ml  mg N/ml 
(Log. 10) 
10.5  0.11 
10.1  0.13 
10.7  0.42 
10.5  0.40 
* All preparations  were digested for 60 minutes at room temperature  with hyaluronidase, 
followed by extraction  with petroleum  ether (See footnote,  Table II). 
TABLE IV 
Effect of RNAse on Crude LDH Agent and PE-Extracted LDH Agent 
Experiment No.  Crude preparations  PE extracted  RNase treated 
1  8.3*  --  8.7:~ 
2  --  5.5  4.9§ 
3  --  6.3  6.5§ 
* Incubated for 24 hours at 37  ° C. 
Incubated for 24 hours at 37  ° C, 100/~g RNase/ml. 
§ Incubated for 1 hour at room temperature,  100/~g RNase/ml. 
A  clear-cut difference between a hyaluronidase-treated preparation  and one 
from which the lipids were removed by additional  PE extraction was not ap- 
parent by electron microscopy (Figs. 2 a and 2 b). This has also been noted with 
lipid-extracted mitochondria (15). 
Size of LDtt  Agent.--Subsequent  to the discovery of the LDH  agent,  con- 
tticting reports concerning its size have appeared. Riley (16) has reported a di- 
ameter of 2 m#, whereas Notkins and Shoehat  (5) reported  a  diameter  of 55 
m/z, Rowson et al. (17) one of 45 m~ and later, Bladen and Notkins (14) one of 
69 X  76 m~. Since our electron micrographs indicate that the LDH agent has a 594  LACTIC  DEttYDROGENASE  AGENT 
diameter of about 50 m#, experiments were performed with PE-extracted LDH 
agent using millipore filters.  The results are presented in Table V. They show 
that no infectious material passed through filters  with a  10 In# pore size,  and 
that a small amount of infectivity passed through the 50 m# filter in only 1 of 3 
experiments. These results are in contrast to those of Riley (16)  who reported 
that the LDH agent passed through millipore filters of 10 m# pore size. 
TABLE V 
Filtration of LDH Agent 
Experi- 
ment No. 
Original  titer 
ID~o/ml (Log. 
1o) 
Titer of filtrate IDs0/ml  (Log. 10) 
10 r~  50 m#  100 r~  220 m#  450 m# 
1  6.5  <2.0  2.1  3.5  --  -- 
2  6.9  <1.0  <1.0  <1.0  4.7  4.7 
3  7.6  <1.0  <1.0  2.9  3.9  -- 
TABLE VI 
Inter reron Production  Following Infection  with  LDH  Agent 
Virus titer ID~o/ml (Log. 10)  Interferon titer/ml 
Days after infection 
Experiment 1"  Experiment 25  Experiment 1  Experiment 2 
1 
2 
3 
8 
14 
9.9 
9.1 
9.7 
7.7 
7.5 
5.9 
24 
3 
7 
<3 
<3 
<3 
* Mice were inoculated i.p. with 10  6.0 LDH agent. 
Mice were inoculated i.p. with 10  8.5 LDH agent. 
Besides  the  reports  on  variation  in  size  of  the  LDH  agent,  Adams  and 
Bowman (18) have reported that two different growth types of the agent exist, 
one reaching  a  maximum fiter of  1@  1,  the other of l0  T ID~0/ml,  which were 
separated by passing through a cellulose  column, and by fractional sedimenta- 
tion. In order to determine whether our preparations contained two  strains,  an 
LDH  agent  preparation  not  treated  with  hyaluronidase  was  centrifuged  at 
105,000 g for 2 hours. As Adams and Bowman found, 99.9 per cent was recov- 
ered from the pellet. However, in contrast to their findings, an additional 99.9 
per cent of the agent remaining in the supernatant was recovered in the pellet 
after recentrifugation at 105,000 g for 18 hours. The final supernatant was in- 
jected into mice and found to give a typical growth curve with a titer of  10  ~°'5 
after 24 hours and of 109.o after 48 hours, indicating the absence of two types of 
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Antigenic Nature of the LDtt A gent.--Since mice, after infection, remain per- 
manently infected, as mentioned before, it might be expected that the LDH 
agent would be of low antigenicity. In order to study this problem, 2 rabbits and 
2 guinea pigs were injected with the purified LDH agent (10  s'° ID per ml). 
For the first injection, the agent suspension was mixed with an equal amount of incom- 
plete Freund's adjuvant. 0.25 ml of this mixture was injected in each foot-pad, and 1 ml in- 
tradermally. In addition, the rabbits received 1 ml intravenously, and the guinea pigs 1 ml 
intraperitoneaUy of the LDH agent  suspension without adjuvant. Thereafter,  the rabbits 
were injected intravenously  and the guinea pigs intraperitoneally with 1 ml LDH agent sus- 
pensions at 7 and 14 days after the first injection and every 14 days thereafter for 14 doses. 
,.-n 
-.4 
5  5 ~ 
4  4  3 
3  3 N  2  \\\(In/erfe  2~(~=~ 
i  I T 
o  O& 
4  15  16  17  18  19  20  21 
DAY  AFTER INFECTION WITH LDH  VIRUS 
NOV or A-F. 
T~xT-Fm. 1. Effect of NDV-induced interferon on the LDH agent titer in the plasma of 
mice. Time of injection of NDV or normal allantoic fluid indicated by arrow. NDV-in'duced 
interferon production is indicated by dotted line. Normal allantoic fluid did not produce inter- 
feron. 
The sera were collected at seven 28-day intervals. Mice were inoculated With 100 infectious 
doses of LDH agent, mixed with equal amounts of either normal serum or of the tWo post- 
immunization  sera, undiluted or in a 1:4 dilution. All groups o2 mice were subsequently found 
to be infected. 
Apparently the  LDH  agent  does  not  stimulate formation of  neutralizing 
antibodies in rabbits or guinea pigs. These findings are in accordance with pre- 
liminary reports by others (19). 
Interferon Production.--Since  the LDH agent can be recovered indefinitely 
from mice once they are infected, it was of interest to determine whether the 
production of interferon by the LDH agent is low, thus allowing persistence of 
the agent. The interferon fiter of mouse plasma was determined at various in- 
tervals after intraperitoneal infection with crude LDH agent. Table VI shows 596  LACTIC DEIIYDROGENASE AGENT 
that the interferon titer varied from less than 3 to 24 units. The technics of in- 
terferon assay and the relation of interferon production to LDH agent growth 
have been discussed elsewhere (20). 
Further experiments showed that the LDH agent titer in the plasma of mice 
with an infection established for 14 days could be temporarily decreased follow- 
ing stimulation of circulating interferon by Newcastle Disease Virus. 
One hundred and thirty mice were inoculated intraperitoneally with 107.0 IDs0 of LDH 
agent. Fourteen days later the pooled plasma of  10 mice contained 106.9 IDs0/ml of LDH 
agent. 
At this time 60 mice were inoculated intravenously with 108.3 PFU of Newcastle disease 
virus, and 60 mice with allantoic fluid. At intervals of 1, 2, 3, 5, and 7 days the pooled plasma 
of 10 mice from each group was assayed for LDH agent concentration. 
The results of a representative experiment, presented in Text-fig. 1, show that 
a temporary decrease in LDH agent titer of about 2 logs occurred after 24 hours, 
and about 1 log after 48 and 72 hours. 
DISCUSSION 
The rapid method of infectivity titration reported here is based on the LDH- 
determination of pooled plasma of 5 mice. Using such plasma,  the following 
criteria should be observed: (a) young, healthy, female mice should be used, un- 
less the male mice of the strain used are known to be docile and thus not infect 
cage mates by biting, as reported by Notkins, et al.  (21); (b) plasma should be 
obtained 4 days after inoculation,  since this is the period of maximal enzyme 
elevation (5); (c) DPNH solutions should be prepared fresh  (22); and (d) he- 
molysed  plasma should be discarded. 
The cultivation of the LDH agent in Ehrlich ascites tumor-bearing mice made 
it possible to obtain quantities of the agent sufficiently large to show by electron 
microscopy that the diameter of the great majority of the particles was about 50 
m~. The observation  that these particles  were frequently seen in single-mem- 
braned vesicles of varying size and occasionally in large  double-membraned 
bodies could explain the observation  by Bladen and Notkins (14) who found a 
number of tailed particles, when the preparations were negatively stained. They 
might well represent  the agent within small  single-membraned  vesicles. The 
presence of LDH agent particles  within single- or double-membraned  vesicles 
could also explain the observation  by Crispens (23) that the small fraction of 
infectious particles, found in the supernatant fluid of his material after centrifu- 
gation in phosphate-buffered  saline, was not inactivated by 1 M MgCl~, if the 
vesicles have a lowered sedimentation velocity, and the vesicle walls protect the 
enclosed virus against MgC12. The presence of these vesicles could similarly ex- 
plain the results by Adams and Bowman (18), who reported that sedimentable 
particles  assayed up to 1@  1 IDs0/ml 20 hours after infection, and decreased to 
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tained their initial  titer of about 10  ~ ID~0/ml.  In this  case it could again be 
assumed that the vesicles are less sedimentable than the free particles although 
they are gorger. 
The presence of varying sizes of vesicles also would explain results by Adams 
and Bowman obtained by chromatography on DEAE-cellulose columns,  since 
the vesicles would elute differently from the free particles, and lead to the elu- 
tion peaks reported by them. 
Neither our filtration experiments, nor the electron micrographs indicate the 
presence of an agent of such small dimensions as those based on filtration experi- 
ments through graded pores (16). Likewise, the results of filtration experiments 
obtained by Notkins and Shochat (5), by Rowson et al.  (17), and the electron 
micrographs presented by Bladen and Notkins (14) do not confirm this smaller 
size. Our experiments also indicate that we do not have two LDH agent strains 
with different infectivity end-points. 
The elevation of both glycolytic and TCA-cycle enzymes, including lactic de- 
hydrogenase in  the mouse plasma  (4),  could be understood if the observed 
vesicles represent loci of multiplication containing the enzymes either necessary 
for or produced as a result of the synthesis of the agent. The disintegration of 
these vesicles might  then lead to an increased  level of these enzymes in the 
plasma,  especially  since  the  agent  decreases  clearance  of enzymes from  the 
plasma (24, 25). 
The gradual decrease of LDH agent titer to a constant value in permanently 
infected mice may be due to a permanent, low or undetectable level of interferon 
production. This was made plausible by experiments in which an increase of cir- 
culating interferon, brought about by subsequent inoculation with Newcastle 
disease virus, temporarily reduced the titer of the LDH agent. 
SIY~rM~.Ry 
The lactic dehydrogenase agent was obtained in quantities sufficient for puri- 
fication studies by growing the virus in Ehrlich ascites tumor-bearing mice. 
A rapid method of titration of the agent is described. 
Subsequent to the standard procedure of concentration of virus by treatment 
with hyaluronidase and centrifugation, lipids were removed by extraction with 
PE, without major loss of infectivity. 
Electron  microscopic  sections  of purified  preparations  contained  particles 
consisting of a dense inner ring of about 25 m# and a less dense ring extending to 
about 50 m/z. 
The particles occur frequently in single-membraned  vesicles of varying size, 
and occasionally  in large double-membraned bodies. 
The purified LDH agent did not stimulate the formation of neutralizing anti- 
bodies in rabbits and guinea pigs. 
The crude LDH agent was found to be a low interferon producer. 598  LACTIC DEHYDROGENASE  AGENT 
Increased interferon, produced by secondary inoculation with Newcastle dis- 
ease virus temporarily decreased the titer of the LDH agent. 
The results of others regarding the nature and the size of the LDH agent are 
interpreted  in regard  to the findings presented,  and  the  role of interferon  in 
permanently LDH agent infected mice is discussed. 
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interferon assays, and Dr. D. W. Alling, Office of the Director, National Institute of Allergy 
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EXPLANATION OF PLATES 
PLATE 37 
FIGS. I  a  to  I  c.  Sections of  LDH agent pellets.  (The lines represent 0.I/~).  × 
98,700, 
FIG. i  a.  Characteristic particles showing inner and outer rings. 
FIGS. i  b and I  c.  Select areas each showing a single membrane-bounded particle. THE  JOURNAL OF  EXPERIMENTAL MEDICINE VOL. 122  PLATE 3 7 
(du  Buy  and  Johnson:  Lactic  dehydrogenase  agent) PLATE 38 
FIGS. 2 a  and 2  b.  Ultra centrifuged pellets of hyaluronidase-treated LDH agent 
showing  double  membrane  structures  containing large  numbers  of  characteristic 
particles. The preparation shown on the left (Fig. 2 a) was additionally treated with 
petroleum ether, that on the right (Fig. 2 b) was not so treated.  (The lines represent 
60 m#).  X  60,500. THE JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 122  PLATE 38 
(du  Buy  and  Johnson:  Lactic  dehydrogenase  agent) 